Bone and Soft Tissue Pathology
2nd edition
Par : , Formats :
- Paiement en ligne :
- Livraison à domicile ou en point Mondial Relay estimée à partir du 15 décembreCet article est actuellement indisponible, il ne peut pas être commandé sur notre site pour le moment. Nous vous invitons à vous inscrire à l'alerte disponibilité, vous recevrez un e-mail dès que cet ouvrage sera à nouveau disponible.
- Retrait Click and Collect en magasin gratuit
- Réservation en ligne avec paiement en magasin :
- Indisponible pour réserver et payer en magasin
- Nombre de pages620
- FormatGrand Format
- PrésentationRelié
- Poids1.972 kg
- Dimensions22,1 cm × 28,2 cm × 2,7 cm
- ISBN978-0-323-75871-0
- EAN9780323758710
- Date de parution05/05/2022
- CollectionFoundations in Diagnostic Path
- ÉditeurElsevier
Résumé
Today's most essential information on bone and soft tissue pathology, in a compact, high-yield format ! Now fully revised to include recent advances in the field, the second edition of Bone and Soft Tissue Pathology, a volume in the Foundations in Diagnostic Pathology series, is an essential foundation text for residents and pathologists. The popular template format makes it easy to use, and new information throughout brings you up to date with what's new in the field, including advances in molecular diagnostic testing and new diagnostic biomarkers.
Practical and affordable, this resource is ideal for study and review as well as everyday clinical practice. Key features of this practical text include : A consistent, user-friendly format that explores each entity's clinical features, pathologic features (gross and microscopic), ancillary studies, differential diagnoses, and prognostic and therapeutic considerations. A focus on specific features of selected neoplastic and non-neoplastic entities, including broad and in-depth differential diagnoses.
Review of normal histology before examining abnormal findings, enabling,you to conveniently compare their characteristics in one place at one time. Clinical information on treatment and prognosis, enabling you to better understand the clinical implications of the diagnosis. Nearly 1,000 full-color, high-quality illustrations with extensive figure legends, as well as abundant boxes and tables throughout.
Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. What's NEW in this edition : Advances in molecular diagnostic testing and its capabilities and limitations, including targeted/personalized medicine. New diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities.
The latest TNM staging and WHO classification systems. New co-editor Dr. Gunnlaugur Pétur Nielsen of Harvard Medical School joins Dr. Andrew L. Folpe and expert, internationally recognized pathologists who keep you up to date with the latest information in the field.
Practical and affordable, this resource is ideal for study and review as well as everyday clinical practice. Key features of this practical text include : A consistent, user-friendly format that explores each entity's clinical features, pathologic features (gross and microscopic), ancillary studies, differential diagnoses, and prognostic and therapeutic considerations. A focus on specific features of selected neoplastic and non-neoplastic entities, including broad and in-depth differential diagnoses.
Review of normal histology before examining abnormal findings, enabling,you to conveniently compare their characteristics in one place at one time. Clinical information on treatment and prognosis, enabling you to better understand the clinical implications of the diagnosis. Nearly 1,000 full-color, high-quality illustrations with extensive figure legends, as well as abundant boxes and tables throughout.
Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. What's NEW in this edition : Advances in molecular diagnostic testing and its capabilities and limitations, including targeted/personalized medicine. New diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities.
The latest TNM staging and WHO classification systems. New co-editor Dr. Gunnlaugur Pétur Nielsen of Harvard Medical School joins Dr. Andrew L. Folpe and expert, internationally recognized pathologists who keep you up to date with the latest information in the field.